Drug intelligence / Profile preview

Lianju capsule

Development stage: Unknown
Lead developer: West China Hospital of Sichuan University
Administration: Oral

Overview

Lianju capsule is a traditional Chinese medicine (TCM) botanical formulation developed by the West China Hospital of Sichuan University. It is specifically indicated for the treatment of the common cold characterized by wind-heat syndrome in adults. The preparation is likely composed of extracts from herbs such as Forsythia (Lianqiao) and Chrysanthemum (Juhua), which are traditionally used in TCM for their heat-clearing and detoxifying properties. The drug has been evaluated in a Phase II, randomized, placebo-controlled, dose-finding clinical trial (ChiCTR-IPR-15006504) to assess its safety and efficacy in relieving symptoms like fever, sore throat, and nasal congestion associated with viral upper respiratory tract infections.

Other names: Lianju jiaonang连菊胶囊

Beyond the preview

Go deeper on Lianju capsule.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lianju capsule.

Explore the full profile